134 related articles for article (PubMed ID: 21376146)
1. The first decade of MALDI protein profiling: a lesson in translational biomarker research.
Albrethsen J
J Proteomics; 2011 May; 74(6):765-73. PubMed ID: 21376146
[TBL] [Abstract][Full Text] [Related]
2. The Lucid Proteomics System for top-down biomarker research.
Jourdain S; Bulman A; Dalmasso E
Arch Physiol Biochem; 2010; 116(4-5):158-62. PubMed ID: 20507259
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a novel, integrated approach using functionalized magnetic beads, bench-top MALDI-TOF-MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasma.
Zhang X; Leung SM; Morris CR; Shigenaga MK
J Biomol Tech; 2004 Sep; 15(3):167-75. PubMed ID: 15331582
[TBL] [Abstract][Full Text] [Related]
4. Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery.
Pieragostino D; Petrucci F; Del Boccio P; Mantini D; Lugaresi A; Tiberio S; Onofrj M; Gambi D; Sacchetta P; Di Ilio C; Federici G; Urbani A
J Proteomics; 2010 Jan; 73(3):579-92. PubMed ID: 19666151
[TBL] [Abstract][Full Text] [Related]
5. MALDI mass spectrometry in prostate cancer biomarker discovery.
Flatley B; Malone P; Cramer R
Biochim Biophys Acta; 2014 May; 1844(5):940-9. PubMed ID: 23831156
[TBL] [Abstract][Full Text] [Related]
6. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
7. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
9. Quantification of target proteins using hydrogel antibody arrays and MALDI time-of-flight mass spectrometry (A2M2S).
Darii E; Lebeau D; Papin N; Rubina AY; Stomakhin A; Tost J; Sauer S; Savvateeva E; Dementieva E; Zasedatelev A; Makarov AA; Gut IG
N Biotechnol; 2009 Sep; 25(6):404-16. PubMed ID: 19552888
[TBL] [Abstract][Full Text] [Related]
10. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
Leung SM; Pitts RL
Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
[TBL] [Abstract][Full Text] [Related]
11. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
Novikova SI; He F; Cutrufello NJ; Lidow MS
Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
[TBL] [Abstract][Full Text] [Related]
12. Achieving in-depth proteomics profiling by mass spectrometry.
Ahn NG; Shabb JB; Old WM; Resing KA
ACS Chem Biol; 2007 Jan; 2(1):39-52. PubMed ID: 17243782
[TBL] [Abstract][Full Text] [Related]
13. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
14. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.
Schaub S; Wilkins J; Weiler T; Sangster K; Rush D; Nickerson P
Kidney Int; 2004 Jan; 65(1):323-32. PubMed ID: 14675066
[TBL] [Abstract][Full Text] [Related]
15. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
[TBL] [Abstract][Full Text] [Related]
16. Analytical considerations for mass spectrometry profiling in serum biomarker discovery.
Whiteley GR; Colantonio S; Sacconi A; Saul RG
Clin Lab Med; 2009 Mar; 29(1):57-69. PubMed ID: 19389551
[TBL] [Abstract][Full Text] [Related]
17. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
18. MALDI-TOF MS as evolving cancer diagnostic tool: a review.
Rodrigo MA; Zitka O; Krizkova S; Moulick A; Adam V; Kizek R
J Pharm Biomed Anal; 2014 Jul; 95():245-55. PubMed ID: 24699369
[TBL] [Abstract][Full Text] [Related]
19. Approaching MALDI molecular imaging for clinical proteomic research: current state and fields of application.
Rauser S; Deininger SO; Suckau D; Höfler H; Walch A
Expert Rev Proteomics; 2010 Dec; 7(6):927-41. PubMed ID: 21142893
[TBL] [Abstract][Full Text] [Related]
20. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
